New COVID Booster Approved From Final Study of Mice, Not Humans, But Using Only Animal Data Is a Needless Gamble

VERIFY: New COVID booster approved from final study of mice, not humans

According to documents on the CDC website, human tests of Moderna’s version of the new booster are still “ongoing.” Right now, there is only final evidence from “8-10 mice” per group.”

The FDA’s website shows for Pfizer the agency also relayed on the final study evidence from “8 mice.” But human trials are also ongoing. So far, the new boosters “showed a similar local reaction and systemic event profile.” That means side effects appear to be about the same including “mild to moderate injection site pain, fatigue, and muscle pain.”

“To advance the Omicron BA.4/BA.5 bivalent vaccine as rapidly as possible, regulators, including the FDA, WHO and EMA, have advised that our submissions be based on safety and immunogenicity data generated in adults with an Omicron BA.1 bivalent vaccine and supported by BA.4/BA.5 bivalent pre-clinical data and BA.4/BA.5 bivalent quality and manufacturing data. These packages follow a similar model to that provided to public health officials who evaluate seasonal flu vaccines each year. Moving forward, this approach may help address the pressing need for vaccines that provide a high level of protection against current and emerging variants of concern so that we can remain vigilant against this evolving virus. The FDA has authorized our Omicron BA.4/BA.5 bivalent vaccine based on clinical data generated in adults with an Omicron BA.1 bivalent vaccine, pre-clinical data with a BA.4/BA.5 bivalent vaccine and BA.4/BA.5 bivalent quality and manufacturing data. Pre-clinical data showed a booster dose of Pfizer and BioNTech’s Omicron BA.4/BA.5- bivalent vaccine generated a strong neutralizing antibody response against Omicron BA.1, BA.2 and BA.4/BA.5 variants, as well as the original wild-type strain. A clinical study investigating the safety, tolerability and immunogenicity of the Omicron BA.4/BA.5 bivalent vaccine in individuals 12 years of age and older is ongoing. Data will be shared with regulators when available. We are facing a virus with an exceptionally high mutation rate, which the nimble mRNA platform is well situated to address. Only the mRNA sequence requires updating to match emerging strains, and utilizing a bivalent vaccine aims to provide broader coverage against known and future COVID-19 variants of concern.”


Read More »

Research suggests that vaccination against COVID via mRNA vaccines may reduce body’s ability to produce key type of antibody.

Vaccines against the coronavirus may impair the body’s ability to produce a key type of antibody, thus potentially limiting the immune system’s defenses against mutated strains of the virus, a new study suggests.

Research suggests that vaccination against COVID via mRNA vaccines may reduce body’s ability to produce key type of antibody.

Some scientists warn that too many shots might actually harm the body’s ability to fight the Covid-19 virus.

Israel Considers 4th Vaccine Dose, but Some Experts Say It’s Premature.

Some scientists warn that too many shots might actually harm the body’s ability to fight the Covid-19 virus. But Israeli experts say there isn’t time to wait.

The proposal to give a fourth dose to those most at risk drew criticism from other scientists and medical professionals, who said it was premature and perhaps even counterproductive. Some experts have warned that too many shots eventually may lead to a sort of immune system fatigue, compromising the body’s ability to fight the virus.

While there is evidence that Omicron, discovered just last month, usually causes milder illness than earlier variants, Israeli officials said that by the time they have clearer information, it might be too late to protect the people most at risk.

Prof. Hagai Levine, an epidemiologist and chairman of the Israel Association of Public Health Physicians, said that Israel was not seeing a sharp rise in infections yet — daily infections are at around 1,200 a day, down from 11,000 at the peak of the Delta wave in August — and there was no evidence that a fourth shot was needed to prevent severe illness from Omicron.

Decreasing antibodies over time is natural, he said, and boosting antibodies may have limited benefit.

Dr. Campbell: Kyle’s experience (Oct 22, 2021)

YouTube: Dr. Campbell: Kyle’s experience ( Oct 22, 2021)

Pericarditis after vaccination, possible inadvertent intravenous administration. Useful links as discussed in this video.

YouTube: Big Health Update / Checking InKyle & April – Ride MTB


Rally in DC, November 2nd

Dr. John Campbell

Despite being pro-vaccine, Dr. Campbell has long warned that the drugs were being administered incorrectly ― re. aspiration of the syringe prior to injection ― and even called for people to petition their respective governments to said effect.



Vaccines Being Administered Incorrectly Causing Myocarditis

Working-Class Americans Are Standing Up for Themselves—and the Left Is Denouncing Them